ArticleJournal of advanced research2024

Ribociclib leverages phosphodiesterase 4 inhibition in the treatment of neutrophilic inflammation and acute respiratory distress syndrome.

Po-Jen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.